Stage FocusSeries A, Series B+
GeographyUS, Europe
TypeCVC
Last Activity2025
Industry Focus
Industries
BiotechMedTechAI Infrastructure
Technical BenchStrong
Investor TypeCVC
ExposureMostly DeepTech Investments
Bio
BMS makes strategic investments directly from its balance sheet rather than through a dedicated CVC fund. Typical deal sizes run $10-50M, with fewer than 2 new investments per year. The approach is selective and strategically driven.
The major venture investment was $180M in Owkin, a French AI company developing technology for clinical trial design, in 2022. BMS also anchored Life Science Partner...
Notable Investments
O
OwkinM
Mirati TherapeuticsK
Karuna TherapeuticsSimilar Funds
AstraZeneca Ventures
Cambridge, United Kingdom
GeneralistBiotechMedTechSeries ASeries B+
New Enterprise Associates (NEA)
Menlo Park, United States
GeneralistBiotechAI InfrastructureMedTechSeedSeries A
Novartis Venture Fund
Basel, Switzerland
GeneralistBiotechMedTechSeedSeries A
Pfizer Ventures
New York, United States
GeneralistBiotechMedTechSeedSeries A
Roche Venture Fund
Basel, Switzerland
GeneralistBiotechMedTechSeedSeries A
Sanofi Ventures
Paris, France
GeneralistBiotechMedTechSeedSeries A